H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 152 Citations 116,079 988 World Ranking 400 National Ranking 9

Research.com Recognitions

Awards & Achievements

2015 - Member of Academia Europaea

2011 - Royal Netherlands Academy of Arts and Sciences

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Philip Scheltens spends much of his time researching Dementia, Alzheimer's disease, Pathology, Neuroscience and Internal medicine. His research integrates issues of Psychiatry and Atrophy in his study of Dementia. His research in Psychiatry intersects with topics in Age of onset, Pediatrics and Cognitive decline.

His work in Alzheimer's disease addresses issues such as Apolipoprotein E, which are connected to fields such as Bioinformatics. His Pathology research is multidisciplinary, incorporating elements of Neurology, Magnetic resonance imaging and Central nervous system disease. Philip Scheltens has researched Internal medicine in several fields, including Gastroenterology, Endocrinology, Oncology and Cardiology.

His most cited work include:

  • The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (9237 citations)
  • Consistent resting-state networks across healthy subjects (3280 citations)
  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)

What are the main themes of his work throughout his whole career to date?

Philip Scheltens mostly deals with Dementia, Disease, Internal medicine, Pathology and Alzheimer's disease. His Dementia research includes themes of Psychiatry, Cognition, Cohort and Atrophy. The various areas that Philip Scheltens examines in his Disease study include Neurology, Neuroscience and Gerontology.

His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Oncology and Cardiology. His studies deal with areas such as Magnetic resonance imaging and Central nervous system disease as well as Pathology. His study connects Degenerative disease and Alzheimer's disease.

He most often published in these fields:

  • Dementia (35.62%)
  • Disease (30.67%)
  • Internal medicine (29.14%)

What were the highlights of his more recent work (between 2018-2021)?

  • Dementia (35.62%)
  • Disease (30.67%)
  • Internal medicine (29.14%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Dementia, Disease, Internal medicine, Cognitive decline and Cognition. His Dementia research focuses on subjects like Neurology, which are linked to Positron emission tomography. His Disease research incorporates themes from Neuroscience, Atrophy and Bioinformatics.

His Internal medicine research includes themes of Oncology and Cardiology. His Oncology research integrates issues from Stage and Neuroimaging. He has researched Cognitive decline in several fields, including Gastroenterology, Executive functions, Hyperintensity and Hazard ratio.

Between 2018 and 2021, his most popular works were:

  • Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia (73 citations)
  • Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype (49 citations)
  • The “rights” of precision drug development for Alzheimer’s disease (44 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Dementia, Disease, Cognitive decline, Internal medicine and Cognition are his primary areas of study. His research in Dementia intersects with topics in Alzheimer's disease, Neurology, Gastroenterology and Gerontology. The various areas that Philip Scheltens examines in his Alzheimer's disease study include Frontotemporal dementia and Bioinformatics.

His Disease study integrates concerns from other disciplines, such as Biomarker, TREM2, Genome-wide association study and Audiology. His studies in Cognitive decline integrate themes in fields like Hyperintensity, Amyloid beta, Neuropsychology, Executive functions and Atrophy. His Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Cardiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann;Guy M. McKhann;David S. Knopman;Howard Chertkow;Bradley T. Hyman.
Alzheimers & Dementia (2011)

9237 Citations

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky.
Lancet Neurology (2007)

4694 Citations

Consistent resting-state networks across healthy subjects

J. S. Damoiseaux;S. A. R. B. Rombouts;F. Barkhof;P. Scheltens.
Proceedings of the National Academy of Sciences of the United States of America (2006)

4132 Citations

Mild cognitive impairment

Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen.
The Lancet (2006)

2753 Citations

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)

2575 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Risk of dementia in diabetes mellitus: a systematic review

Geert Jan Biessels;Salka Staekenborg;Eric Brunner;Carol Brayne.
Lancet Neurology (2006)

2132 Citations

Revising the definition of Alzheimer's disease: a new lexicon.

Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings.
Lancet Neurology (2010)

2082 Citations

A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

L. O. Wahlund;F. Barkhof;F. Fazekas;L. Bronge.
Stroke (2001)

1769 Citations

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

Frederik Barkhof;Massimo Filippi;David H. Miller;Philip Scheltens.
Brain (1997)

1644 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Philip Scheltens

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 805

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 771

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 330

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 310

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 309

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 296

John R. Hodges

John R. Hodges

University of Sydney

Publications: 290

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 277

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 252

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 251

Bruce L. Miller

Bruce L. Miller

University of California, San Francisco

Publications: 248

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 243

John T. O'Brien

John T. O'Brien

University of Cambridge

Publications: 243

Oskar Hansson

Oskar Hansson

Lund University

Publications: 235

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 234

Something went wrong. Please try again later.